Related Experiment Video
Updated: Jul 17, 2026
Stabilizing Hepatocellular Phenotype Using Optimized Synthetic Surfaces
Published on: September 26, 2014
Hexafluoropropylene oxide dimer acid exposure disrupts hepatic lipid metabolism by modulating the RBP4-STRA6 axis
Xinyu Li1, Qiaoli Zhou2, Wenhua Wang3
1Department of Endocrinology, Genetics and Metabolism, Children's Hospital of Nanjing Medical University, Nanjing, China; Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China; Department of Microbiology and Vaccinology, School of Public Health, Nanjing Medical University, Nanjing, China.
None:
Hexafluoropropylene oxide dimer acid (GenX), an emerging per- and polyfluoroalkyl substance (PFAS) detected in environmental matrices and drinking water sources, raises significant environmental health concerns due to its persistence and potential toxicity. This study investigated the hepatotoxic mechanisms of GenX through multi-omics approaches using in vivo (zebrafish) and in vitro (HepG2 cells) models. Environmentally relevant GenX exposure induced dose-dependent increases of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol (TC), and triacylglycerol (TAG), accompanied by hepatic histopathological damage. Multi-omics analyses revealed that GenX disrupted hepatic lipid homeostasis by activating de novo lipogenesis (DNL) and TAG biosynthesis pathways, with retinol binding protein 4 (RBP4) identified as a critical molecular mediator. Mechanistically, GenX may trigger downstream signaling by enhancing the RBP4-STRA6 interaction, promoting excessive fatty acid synthesis and subsequent hepatic lipid accumulation. Genetic inhibition of RBP4 attenuated GenX-induced lipid deposition. Overall, our findings elucidate a novel RBP4-mediated mechanism underlying GenX-driven hepatotoxicity and provide critical insights into the health implications of PFAS alternatives.
